Literature DB >> 14118680

TREATMENT OF CARDIAC ARRHYTHMIAS WITH SYNCHRONIZED ELECTRICAL COUNTERSHOCK.

K W BROWN, E H WHITEHEAD, J D MORROW.   

Abstract

Synchronized electrical countershock is an intriguing new method for the treatment of ectopic tachycardias. The authors applied this treatment to 20 patients with chronic atrial fibrillation and, in 17 patients, sinus rhythm was restored immediately. An additional four patients with atrial flutter were successfully converted to sinus rhythm. One patient developed a hemiplegia two weeks after cardioversion. No other untoward side effects were observed. In two patients with ventricular fibrillation electrical countershock terminated the arrhythmia. After successful cardioversion of atrial fibrillation, a maintenance dose of quinidine is given to help maintain sinus rhythm. In spite of this precaution, one-half of the patients reverted to atrial fibrillation within a month. The quinidine was administered for two to three days in advance of cardioversion; on this regimen, 10 of 34 patients reverted to sinus rhythm on quinidine alone and did not require countershock. The exact place of this treatment of cardiac arrhythmias has not yet been clearly defined.

Entities:  

Keywords:  AURICULAR FIBRILLATION; AURICULAR FLUTTER; ELECTROTHERAPY; QUINIDINE; VENTRICULAR FIBRILLATION

Mesh:

Substances:

Year:  1964        PMID: 14118680      PMCID: PMC1922207     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  Conversion of atrial fibrillation to sinus rhythm by direct-current shock.

Authors:  S ORAM; J P DAVIES; I WEINBREN; P TAGGART; L D KITCHEN
Journal:  Lancet       Date:  1963-07-27       Impact factor: 79.321

2.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.

Authors:  B LOWN; R AMARASINGHAM; J NEUMAN
Journal:  JAMA       Date:  1962-11-03       Impact factor: 56.272

  2 in total
  3 in total

1.  Rate control in atrial fibrillation, insight into the RACE II study.

Authors:  H F Groenveld; H J G M Crijns; J G P Tijssen; M Alings; H L Hillege; Y S Tuininga; M P Van den Berg; D J Van Veldhuisen; I C Van Gelder
Journal:  Neth Heart J       Date:  2013-04       Impact factor: 2.380

2.  Engineering and physiological considerations of direct capacitor-discharge ventricular defibrillation.

Authors:  L A Geddes; W A Tacker
Journal:  Med Biol Eng       Date:  1971-05

3.  Direct current shock therapy of cardiac arrhythmias.

Authors:  P Szekely; G A Batson; D C Stark
Journal:  Br Heart J       Date:  1966-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.